Filing Details

Accession Number:
0000905718-20-000722
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-06 16:02:07
Reporting Period:
2020-06-26
Accepted Time:
2020-07-06 16:02:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484565 Soleno Therapeutics Inc SLNO () X0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397144 Llp Abingworth 38 Jermyn Street
London X0 SW1Y 6DN
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-26 3,333,330 $1.65 10,302,602 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Footnotes
  1. The shares were purchased from the underwriters in a firm-commitment underwritten public offering of shares of the Issuer's common stock that closed on June 26, 2020. The shares are held by Abingworth Bioventures VII, LP ("Abingworth VII"). Abingworth Bioventures VII GP LP ("Abingworth GP") serves as the general partner of Abingworth VII. Abingworth General Partner VII LLP, serves as the general partner of Abingworth GP. Abingworth VII (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner VII LLP) has delegated to Abingworth LLP ("ALLP"), all investment and dispositive power over the securities held by Abingworth VII. ALLP holds the reported securities indirectly through Abingworth VII. ALLP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein.
  2. This report shall not be deemed an admission that the reporting person, Abingworth or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.